About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Texas | 660 Studies

Clinical Trials Pancreatic CancerTexas

Pancreatic Cancer Clinical Trials in Texas

Find 660 clinical trials for pancreatic cancer near Texas. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 301-320 of 660 trials

CompletedBinimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic CancerThis phase I trial studies the best dose of hydroxychloroquine when given together with binimetinib in treating patients with KRAS gene mutated pancreatic cancer that has spread…NCT04132505·Houston, Texas RecruitingThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyThe Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based…NCT04075305·Pittsburgh, Pennsylvania and 17 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study of Botensilimab in Participants With Metastatic Pancreatic CancerThe goal of this clinical trial is to test if the addition of botensilimab to standard chemotherapy improves the efficacy compared to just chemotherapy alone in participants with…NCT05630183·Scottsdale, Arizona and 35 others

CompletedA Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer SubjectsThe purpose of this study is to determine the recommended dose and regimen for the orally administered MEK inhibitor GSK1120212 dosed in combination with everolimus in subjects…NCT00955773·Nashville, Tennessee and 2 others

TerminatedAntineoplaston Therapy in Treating Patients With Stage IV Pancreatic CancerCurrent therapies for Stage IV Pancreatic Cancer provide very limited benefit to the patient.NCT00003531·Houston, Texas

RecruitingExtending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III TrialThe EXPAND trial (EXtending outcomes for PAncreas cancer patients with Nominal oligometastatic Disease) is a randomized phase III trial assessing the efficacy of MDT to improve…NCT06593431·Camden, New Jersey and 3 others

CompletedS0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryThis randomized phase I/II trial is studying the side effects and best dose of monoclonal antibody therapy when given together with gemcitabine hydrochloride and erlotinib…NCT00617708·Jonesboro, Arkansas and 145 others

CompletedFT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid TumorsFT500 is an off-the-shelf, iPSC-derived NK cell product that can bridge innate and adaptive immunity, and has the potential to overcome multiple mechanisms of immune checkpoint…NCT03841110·San Diego, California and 3 others

CompletedAdjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic CancerRATIONALE: Drugs used in chemotherapy, such as fluorouracil and cisplatin, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00059826·Gainesville, Florida and 13 others

CompletedDose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid TumorsThe purpose of this study is to determine if TH-302, in combination with A) Gemcitabine, or B) Docetaxel or C) Pemetrexed methotrexate, are safe and effective in the treatment of…NCT00743379·Scottsdale, Arizona and 10 others

RecruitingTh-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic AdenocarcinomaThis is a phase 1, first in human, dose escalation study for safety and feasibility of multi-dose dendritic cell (DC) therapy for pancreatic ductal adenocarcinoma (PDAC) including…NCT04157127·Houston, Texas and 2 others

CompletedGemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the PancreasRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00012220·Anniston, Alabama and 75 others

RecruitingComputed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary CancerThis trial studies how well computed tomography works in diagnosing patients with pancreatic or hepatobiliary cancer.NCT02361320·Houston, Texas

UnknownCoordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic CancerThe data management systems, auditing, and monitoring effort are supported by the MD Anderson Cancer Center Clinical Research Support Center (CRSC).NCT03058926·Houston, Texas

CompletedTrial of NanoPac® in Subjects With Locally Advanced Pancreatic AdenocarcinomaOpen-label, dose-escalating, Phase IIa trial of NanoPac® to treat subjects with locally advanced pancreatic adenocarcinoma via direct intratumoral injection.NCT03077685·Los Angeles, California and 3 others

TerminatedA Study of PF-08046052/SGN-EGFRd2 in Advanced Solid TumorsThis study will test the safety of a drug called PF-08046052/SGN-EGFRd2 in participants with advanced solid tumors. It will also study the side effects of this drug.NCT05983133·Los Angeles, California and 23 others

CompletedA First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051bDS-6051b is an orally administered inhibitor of the tyrosine kinases (ROS1) and neurotropic tyrosine kinase receptors (NTRK).NCT02279433·Scottsdale, Arizona and 5 others

RecruitingTesting the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsThis phase II trial studies the effect of capecitabine and temozolomide after surgery in treating patients with high-risk well-differentiated pancreatic neuroendocrine tumors.NCT05040360·Anchorage, Alaska and 447 others

UnknownENB003 Plus Pembrolizumab Phase 1b/2a in Solid TumorsFirst-in Human study evaluating the safety, tolerability and efficacy of ENB003 in combination with Pembrolizumab in solid tumors. The study is separated into two parts.NCT04205227·Los Angeles, California and 4 others

Active not recruitingStudy to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid TumorsThe study will determine the recommended Phase 2 dose (RP2D) of livmoniplimab (ABBV-151) administered as monotherapy and in combination with budigalimab (ABBV-181) as well as to…NCT03821935·Springdale, Arkansas and 63 others

PreviousPage 16 of 33Next

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia